» Articles » PMID: 35547453

Efficacy of Sacroiliac Joint Injection With Anesthetic and Corticosteroid: A Prospective Observational Study

Overview
Journal Cureus
Date 2022 May 13
PMID 35547453
Authors
Affiliations
Soon will be listed here.
Abstract

Sacroiliac joint injection aims to provide pain relief, improve work status, and early return to work. We aimed to investigate the role of corticosteroid and anesthetic mixture to provide short- and long-term pain relief in patients with sacroiliac joint pain. This prospective observational study included 27 patients with sacroiliac joint dysfunction who received a combination of triamcinolone and ropivacaine for sacroiliac joint injection followed by three scheduled visits at four weeks, eight weeks, and six months. The pain was assessed using visual analogue scale (VAS), physician's assessment on the number of positive provocative tests, and patients' self-reported assessment to evaluate their functional outcome. At the four weeks and eight weeks follow up evaluations, the mean VAS reduced from 5.85 (±1.03) at baseline to 3.30 (±1.77) at four weeks, 3.30 (±1.86) at eight weeks, and 3.00 (±1.86) at six months. At each interval, improvement in terms of clinical assessment using a series of provocative tests was seen with a mean of 1.37 (±1.33), 1.63 (±1.31), and 1.48 (±1.05) at four weeks, eight weeks, and six months, respectively. For the functional effectiveness parameters (Roland-Morris questionnaires), the sacroiliac joint (SIJ) injected with these drugs combination showed a more significant improvement in symptoms and function, baseline (13.56±3.36), at four weeks (9.04±3.33), at eight weeks (9.07±4.13), and six months (8.26±4.92). Using the one-way repeated measures ANOVA, the SIJ pain, provocative test, and functional outcome significantly improved over time after injection with triamcinolone and ropivacaine (p<0.001). No complications of the administration of these medications were noted. Our findings support the intermediate-term (six months) effectiveness and safety of a combination of corticosteroid and anesthetic injection for patients with SIJ dysfunction who failed conservative treatment.

Citing Articles

Injective Treatments for Sacroiliac Joint Pain: A Systematic Review and Meta-analysis.

Ruffilli A, Cerasoli T, Barile F, Manzetti M, Viroli G, Traversari M Indian J Orthop. 2024; 58(6):637-649.

PMID: 38812868 PMC: 11130093. DOI: 10.1007/s43465-024-01164-w.

References
1.
Murakami E, Kurosawa D, Aizawa T . Treatment strategy for sacroiliac joint-related pain at or around the posterior superior iliac spine. Clin Neurol Neurosurg. 2018; 165:43-46. DOI: 10.1016/j.clineuro.2017.12.017. View

2.
Liliang P, Lu K, Weng H, Liang C, Tsai Y, Chen H . The therapeutic efficacy of sacroiliac joint blocks with triamcinolone acetonide in the treatment of sacroiliac joint dysfunction without spondyloarthropathy. Spine (Phila Pa 1976). 2009; 34(9):896-900. DOI: 10.1097/BRS.0b013e31819e2c78. View

3.
Luukkainen R, Nissila M, Asikainen E, Sanila M, Lehtinen K, Alanaatu A . Periarticular corticosteroid treatment of the sacroiliac joint in patients with seronegative spondylarthropathy. Clin Exp Rheumatol. 1999; 17(1):88-90. View

4.
Karabacakoglu A, Karakose S, Ozerbil O, Odev K . Fluoroscopy-guided intraarticular corticosteroid injection into the sacroiliac joints in patients with ankylosing spondylitis. Acta Radiol. 2002; 43(4):425-7. DOI: 10.1080/j.1600-0455.2002.430415.x. View

5.
Maugars Y, Mathis C, Berthelot J, Charlier C, Prost A . Assessment of the efficacy of sacroiliac corticosteroid injections in spondylarthropathies: a double-blind study. Br J Rheumatol. 1996; 35(8):767-70. DOI: 10.1093/rheumatology/35.8.767. View